Zymeworks (ZYME) Current Deferred Revenue (2021 - 2026)

Zymeworks' Current Deferred Revenue history runs 6 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• In Q1 2026, Current Deferred Revenue fell 94.55% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (down 94.55% YoY), while the FY2025 annual figure was $2.4 million, down 90.55% from the prior year.
• Current Deferred Revenue came in at $2.1 million for Q1 2026 at Zymeworks, down from $2.4 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $41.8 million in Q3 2024 to a low of $93000.0 in Q3 2023.
• A 5-year average of $16.7 million and a median of $3.8 million in 2025 frame the typical range for Current Deferred Revenue.
• Across the five-year window, Current Deferred Revenue sank 99.72% in 2023 and soared 44840.86% in 2024, its largest moves.
• Zymeworks' Current Deferred Revenue stood at $2.4 million in 2022, then soared by 57.2% to $3.7 million in 2023, then jumped by 592.08% to $25.6 million in 2024, then tumbled by 90.55% to $2.4 million in 2025, then decreased by 14.06% to $2.1 million in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $2.1 million, $2.4 million, and $3.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison